Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Dutta Sayantanee |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Cutillas, PR; Borek, WE; Christopher, JA; Nobre, LV; Campbell, A; Kelsall, J; Pedicona, F; Nawaz, N; Perkins, DN; Cardoso, PM; Arruda, A; Ambinder, AJ; Dutta, S; Gallipoli, P; Sill, H; Ghiaur, G; Minden, MD; Williamson, A; Gribben, JG; Dokal, AD
Multi-drug algorithm to accurately predict best first-line treatments in newly-diagnosed acute myeloid leukemia (AML)
J CLIN ONCOL. 2024; 42(16):
[Poster]
Web of Science
Dutta, S; Rezania, S; Lyssy, F; Lind, K; Vosberg, S; Thallinger, G; Zebisch, A; Wölfler, A; Pabst, G; Foßelteder, J; Reinisch, A; Sill, H;
Deciphering the molecular mechanism of mesenchymal stromal cell mediated drug resistance in acute myeloid leukemia.
29th European Hematology Association Congress; JUN 13-16, 2024; Madrid, SPAIN. 2024.
[Poster]
Edtmayer, S; Witalisz-Siepracka, A; Zdársky, B; Weiss, S; Eder, T; Dutta, S; Wieser, R; Sill, H; Grebien, F; Stoiber, D
STAT3β represses interferon signaling in acute myeloid leukemia contributing to favorable disease outcomes
KLIN PADIATR. Abstracts. 2024; 236(3):204-204.-35. Jahrestagung der Kind-Philipp-Stiftung für pädiatrisch onkologische Forschung; JUN 5-8, 2024; Wilsede, GERMANY.
Doi: 10.1055/s-0044-1786570
[Poster]
Web of Science
FullText
FullText_MUG
Lind, K; Dutta, S; Foßelteder, J; Pabst, G; Reinisch, A; Wölfler, A; Zebisch, A; Sill, H;
Deciphering early steps of TP53 aberrant human leukemogenesis.
29th European Hematology Association Congress; JUN 13-16, 2024; Madrid, SPAIN. 2024.
[Poster]
Dutta, S; Kerbs, P; Rothenberg-Thurley, M; Ksienzyk, B; Krebs, S; Blum, H; Spiekermann, K; Metzeler, KH; Herold, T; Dandachi, N; Vosberg, S; Greif, PA;
FREQUENT TRUNCATING MUTATIONS IN TET2 GENE AND A DISTINCT DNA METHYLATION SIGNATURE CHARACTERIZES ACUTE MYELOID LEUKEMIA WITH ISOLATED TRISOMY 4
ANN HEMATOL. 2023; 102(SUPPL 1):S26-S27.-ACUTE LEUKEMIAS XVIII .ISALXVIII
BIOLOGY AND TREATMENT STRATEGIES; March 19-20, 2023; Munich Germany.
[Poster]
Web of Science
Galhuber, M; Michenthaler, H; Foßelteder J; Dutta, S; Reinisch, A; Krtic, J; Prokesch, A
Trp53 hotspot mutants’ response to HCC combination therapy
EMBO Workshop "Systems approaches in cancer"; JUN 26-30, 2023; Split, CROATIA. 2023.
[Poster]
Lyssy, F; Lind, K; Zöscher, F; Zebisch, A; Wölfler, A; Pabst, G; Fosselteder, J; Reinisch, A; Sill, H; Dutta, S
Modelling drug resistance conferred by mono- and bi-allelic TP53 aberrations using isogenic AML cell lines
ONCOL RES TREAT. 2023; 46: 188-189.
[Poster]
Web of Science
FullText
Dutta, S; Kerbs, P; Rothenberg-Thurley, M; Ksienzyk, B; Krebs, S; Blum, H; Spiekermann, K; Metzeler, KH; Herold, T; Vosberg, S; Greif, PA
Acute Myeloid Leukemia with Isolated Trisomy 4 Is Characterized By Frequent Mutations of TET2 and a Distinct DNA Methylation Signature
BLOOD. 2022; 140: 8912-8913.-64th American Society of Hematology Annual Meeting and Exposition; December 10-13, 2022; New Orleans USA.
Doi: 10.1182/blood-2022-168939
[Poster]
Web of Science
FullText
FullText_MUG
Dutta,S; Moritz,J; Pregartner,G; Thallinger,G; Brandstätter, I; Lind,K; Rezania,S; Lyssy,F; Reinisch,A; Zebisch,A; Berghold,A;Wölfler, A and Sill, H
AML and MDS patients with TP53 aberrations – a single cancer center experience.
Magazine of European Medical Oncology“. 2022; -Frühjahrestagung ÖGHO 2022; APR 8-10 2022; Graz, Austria.
[Oral Communication]
Dutta S, Pregartner G, Rücker FR, Heitzer H, Zebisch A, Bullinger L, Berghold A, Döhner K, Sill H
Functional Classification of TP53 Mutations in Acute Myeloid Leukemia
Blood. 2019; 134, Suppl. 1: -American Society of Hematology, Annual Meeting; DEC 6-10, 2019; Orlando.
[Poster]
DuttaS, Pregartner G, Rücker F, Heitzer E,Zebisch A, Bullinger L,Berghold A, Döhner K Sill H
Functional Classification of TP53 Mutations in Acute Myeloid Leukemia
German-Austrian Acute Myeloid Leukemia study group (AML-SG) Study meeting ; May 23-24, 2019; Vienna, Austria. 2019.
[Oral Communication]
Dutta S, Kerbs P, Vosberg S, Rothenberg-Thurley M, Ksienzyk B, Krebs,S Blum H, Hiddemann W Spiekermann K, Metzeler KH, Herold T, Greif PA
Acute Myeloid Leukemia with Isolated Trisomy 4 is Characterized by Frequent Mutations of TET2
SFB 1243 International Symposium: Cancer Evolution; March 1-3, 2018; Munich. 2018.
[Poster]
Leubolt G, Tizazu B, Dutta S, Cusan M, Sippenauer T, Istvanffy R, Oostendorp R, Hiddemann W, Greif PA
GATA2 Zinc Finger Mutations Affect DNA-Binding and Promote Granulopoietic Differentiation
Blood (2018) 132 (Supplement 1): 2779.. 2018; - American Society of Hematology (ASH) Annual meeting 2018; Dec 1-4 2018; San Diego, California, USA.
[Poster]
FullText
Dutta S, Krause A, Vosberg S, Herold T, Ksienzyk B, Quintanilla-Fend L, Tizazu B, Graf A, Krebs S, Blum H, Greif PA, Schneider M, Dahlhof M, Spiekermann K, Zimber-Strobl U, Wolf E, Bohlander SK
Analysis of the Tissue-Specific Expression Requirements and Identification of Cooperating Mutations for Leukemogenesis in an Inducible CALM/AF10 Knock-in Mouse Model
Blood Journal Volume 124, Issue 21 . 2014; -56th ASH Annual meeting (American Society of Hematology) ; Dec 6-9, 2014; San Francisco, USA.
[Oral Communication]
FullText
Dutta S, Krause A, schneider M, Dahlhoff M, Tizazu B, Wolf E, Bohlander SK
TISSUE AND DIFFERENTIATION STAGE-SPECIFIC EXPRESSION OF THE
CALM/AF10 FUSION PROTEIN IS REQUIRED FOR LEUKEMOGENESIS
EHA 18 Abstract book. 2013; -18th Congress of the European Hematology Association; June 13-16, 2013; Stockholm, Sweden.
[Oral Communication]
FullText